Normalac (Lactulose)

Lactulose, the active ingredient in Normalac, is an osmotic laxative presented as an oral solution for oral use. It softens stool to relieve constipation and lowers blood ammonia levels, helping manage hepatic encephalopathy in patients with liver disease. It is widely used in clinical practice across Europe and is recognized for its efficacy and safety profile when used as directed.

GNH USA supplies Normalac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export.

Normalac (lactulose) acts on the gastrointestinal tract to treat conditions related to impaired bowel motility and elevated blood ammonia. - Constipation: softens stool and increases bowel frequency to relieve occasional or chronic constipation. - Hepatic encephalopathy: reduces blood ammonia by acidifying colonic contents, improving mental status in patients with liver dysfunction. - Prevention of hepatic encephalopathy recurrence: maintains low ammonia levels to help prevent future episodes in chronic liver disease.

Lactulose may cause a range of adverse reactions, most of which are related to its laxative action.

Common Side Effects: - Abdominal cramping: mild to moderate stomach pain that may accompany bowel movements. - Flatulence: increased intestinal gas causing bloating. - Diarrhea: loose stools that can occur if the dose is high. - Nausea: feeling of queasiness, often transient. - Thirst: increased desire for fluids due to fluid loss in stool.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss leading to dizziness or low blood pressure. - Electrolyte disturbances: abnormal levels of potassium, sodium or magnesium that may require monitoring. - Allergic reactions: rash, itching, or urticaria indicating hypersensitivity. - Acute colonic pseudo‑obstruction (Ogilvie’s syndrome): rare blockage‑like condition requiring medical attention.

When using Normalac, several precautionary measures help ensure safe and effective therapy. - Assess renal function: adjust dose in patients with impaired kidney clearance. - Monitor electrolytes: check potassium and sodium levels during prolonged treatment. - Use cautiously in diabetes: lactulose contains sugar that may affect blood glucose. - Avoid in bowel obstruction: the drug can worsen blockage and cause distension. - Discontinue if severe diarrhea occurs: to prevent dehydration and electrolyte loss. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Lactulose can interact with certain medicines, altering their effectiveness or safety.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of hyperkalemia due to reduced potassium excretion. - Magnesium‑containing antacids: may increase laxative effect and cause diarrhea. - Oral antibiotics: can disrupt gut flora, diminishing lactulose’s ammonia‑lowering action.

Moderate Interactions (Monitor Closely): - Other laxatives: additive effect may lead to excessive stool fluid loss. - Probiotic supplements: may reduce the acidifying effect of lactulose in the colon. - Metformin: monitor for potential lactic acidosis in patients with liver disease.